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Members of the public and patients repeatedly indicate their willingness to take part in research, but 1 
current UK research governance regulations provide complex rules about gaining consent.  Research 2 
participation registers that seek consent from participants to be approached about future studies have 3 
several potential benefits, including increased research participation across clinical and healthy populations; 4 
simplified recruitment to healthcare research; support for people’s autonomy in decision-making; and 5 
improved efficiency and generalisability of research.  These potential benefits have to be balanced against 6 
ethical and governance considerations.  With appropriate processes in place, seeking prospective consent to 7 
be approached about future studies from patients and members of the public could potentially increase 8 
public participation in health research without compromising informed consent and other ethical principles.  9 
 10 
Introduction 11 
The quality and generalisability of health research findings are dependent on the participation of sufficiently 12 
large numbers of volunteer participants who reflect the diversity of the population. Previous research in the 13 
United Kingdom (UK) has shown that 69% of the public are keen to participate in healthcare research1.  14 
Despite this, patients and the public in the UK face at least two important barriers to research participation. 15 
First, to protect potential health research participants the UK research governance framework prevents 16 
researchers from contacting eligible patients directly; instead the initial contact must come from the clinician 17 
responsible for their care2.  Thus clinicians currently act as the gatekeepers for access to research both for 18 
researchers and the potential participants themselves.  Second, there is currently no system for matching 19 
potentially eligible prospectively consented participants to a range of suitable research studies2, so NHS and 20 
academic researchers often encounter difficulties in recruiting participants3 to non-clinical research.  21 
As a consequence, recruitment is often complicated and slow, and some projects fail.  Despite the fact that 22 
many studies and researchers find it difficult to recruit suitable people and that many people would participate 23 
if they knew a suitable study was available, mechanisms to match potentially eligible participants to suitable 24 
research studies often do not exist. 25 
One approach to facilitate participation by patients and the public is systematically to ascertain their 26 
willingness and interest in participating in future healthcare research and pro-actively seek prospective 27 
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consent for future re-contact by researchers for studies for which they are eligible4.  By linking records to basic 28 
demographic and medical history details, researchers can identify eligible and willing participants quickly and 29 
efficiently5. Despite the possible benefits, this proactive seeking of consent for future re-contact is uncommon, 30 
with some exceptions4,5,6. 31 
There are several types of research registers that seek consent from patients or members of the public for 32 
ongoing contact regarding future research. This consent is usually prospective with regard to future research in 33 
which an individual registrant may have a potential interest and for which they may be eligible to participate. 34 
The consent contains two aspects: (1) consent to be enrolled onto the register to provide basic socio-35 
demographic and clinical details, or alternatively to have their details linked to health service related 36 
databases; and (2) consent to be contacted at a later date about particular research studies for which they 37 
may be eligible, and to receive relevant information to enable them to make decisions about participation. The 38 
aims of such registers vary depending on the type of research being undertaken or the particular clinical 39 
population being studied.  Several research registers have been established around particular health problems 40 
or medical specialties to facilitate specific research participation, such as a dementia register7 and rare 41 
diseases register8.  Only a relatively small number aim to encourage broad-based research participation, that 42 
are non-disease specific, public participation or population based registers. Examples include the Scottish 43 
Health Research Register (SHARE)9 run by NHS Scotland and ‘ResearchMatch’ in the USA10.  44 
Moving from disease- or hospital-specific registers to a public participation register provides opportunities for 45 
a wide range of people and patients to be involved in a range of research studies, with the added value of 46 
potential control groups that may be suitable in some situations.  However, given the focus away from specific 47 
diseases in specific healthcare setting, a major challenge is to obtain sufficient information so that participants 48 
can be informed about studies relevant to them.  A register may entail registrants volunteering information 49 
about their health via questionnaire on entry, but this is a rather static approach that may become difficult to 50 
manage.   Alternatively, patients and the public give permission in advance for their electronic health records 51 
(EHRs) to be used to assess whether they met the eligibility criteria for studies. 52 
Potential benefits of non-disease specific research registers 53 
Research registers are set up to improve healthcare through increasing research participation, and conducting 54 
pragmatic studies more efficiently and on a larger scale11. However, the policy context and legislative 55 
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framework around research governance are crucial factors in facilitating or inhibiting the development of 56 
research participation registers. In the UK, a system of research regulation and governance, the Research 57 
Governance Framework, was instituted in 2001 and re-issued in 2005 to restore public confidence in health 58 
research following incidents of poor practice. This has resulted in tight controls on recruitment processes and 59 
data collection. The framework has been criticised for introducing burdensome administrative processes, long 60 
delays and impeding scientific progress through inflexible procedures (for example Dixon-Wood12), although 61 
recent legislative and policy changes have sought to improve this situation. Furthermore, mechanisms to 62 
encourage greater public involvement in the prioritisation and design of studies, using patient experience to 63 
improve research, and national campaigns for improving participation in research have been implemented 64 
such as the NIHR ‘OK to ask’ campaign13. These mechanisms are aimed at raising awareness of the importance 65 
of health research, which in turn is expected to lead to greater willingness to participate in studies. These 66 
recent developments create conditions that facilitate the implementation of research participation registers in 67 
the UK.  68 
Much research requires the collection and exchange of electronic patient records and clinical data, and 69 
depends on the interoperability of data collection systems and standardised storage. A sustainable strategy for 70 
such a digital infrastructure across the English NHS is being developed and data linkage will be important for 71 
clinical reasons, as well as for research purposes. While the digital infrastructure for data linkage is being set 72 
up, research participation registers are capable of storing large amounts of patient generated data. Therefore, 73 
security and privacy in collecting, storing and sharing people’s data are major factors in ensuring public trust in 74 
any research participation register. However, public trust in initiatives to extract, store and share data digitally 75 
cannot be taken for granted even when protective infrastructures and legislation are in place. As Carter et al 76 
(2015) argue, the social legitimacy of such undertakings has to be secured through engagement and public 77 
approval and what they term a ‘social licence’, based on reciprocity, non-exploitation and service of the public 78 
good. Practical implications for access to individual information and recruitment to studies is highly sensitive 79 
and operating procedures will need to be carefully developed to ensure public confidence in the system. Any 80 
research participation register would need to actively work with public to secure such a social licence.  The 81 
authors believe that prospective consent employed within a research register model goes some way towards 82 
upholding the NHS constitution, provides an informed choice to members of the public about research 83 
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involvement and allows researchers access to consented data.  Due to the issues associated with Care.Data 84 
(Carter et al, 2015), the authors believe that the prospective consent register model will currently not be 85 
widely accepted at a UK wide level, but can be suitable integrated at NHS Trust and Clinical Commissioning 86 
Group level.   87 
The validity and generalisability of research findings are contingent upon the participation of volunteers drawn 88 
from diverse populations in terms of ethnicity, socioeconomic status, geographic location, health literacy and 89 
health status. However, many of these groups are underrepresented in health research. The term ‘hard to 90 
reach’ has become shorthand for describing individuals for whom the usual strategies do not work and is 91 
increasingly being used in the research literature to construct the problem of non-participation in research by 92 
certain groups, implying that the blame for this underrepresentation lies with these groups themselves14. 93 
However, Wendler15 demonstrated that minority ethnic communities were on the whole no less likely, and 94 
possibly more likely than white people, to agree to participate in health studies. The authors identified the 95 
reduced likelihood of being invited to participate as the main barriers to participation by minority ethnic 96 
groups rather than a lack of willingness or distrustful attitudes. Reliance on one method of recruitment of 97 
minority groups to health and clinical studies such as a research participation register is unlikely to succeed 98 
and issues such as the use of easily accessible research sites, reimbursement of travel expenses and help with 99 
child care and carer responsibilities will be equally important in enabling people to enrol into a study and 100 
prevent drop-out (Wendler et al, 2006). There is evidence of novel methods to encourage previously 101 
underrepresented groups to join research registers through working with credible and respected opinion 102 
leaders, advertisements in particular locations, and the engagement of community champions to spread 103 
information (Rogers et al, 2007).  The Illinois Women’s Health Registry has used various recruiting strategies, 104 
including speaking engagements, health fairs and billboards, alongside virtual marketing and social networking 105 
(Bristol-Gould et al, 2010).  The development of a research participation register may enable greater access to 106 
information about health and clinical research studies by providing unbiased access mechanisms, but only if 107 
sufficiently large numbers from minority groups are signed up to the register to enable meaningful answers to 108 
relevant research questions.  109 
Furthermore, high profile mechanisms to encourage greater patient and public involvement in the 110 
prioritisation and design of research studies are being implemented in a range of settings, using a variety of 111 
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methods.  It has been recognised that a greater level of public trust and confidence is held in research projects 112 
where public and patient involvement has been prioritised 113 
(http://www.hra.nhs.uk/documents/2013/08/patient-and-public-workshops-dialogue-report.pdf).  Therefore, 114 
the role of Public and Patient Involvement in the design, development and implementation of research 115 
registers should be promoted, in order to enhance the perceived utility and user friendly nature of research 116 
registers to the general public.   117 
Prospective consent: benefits and drawbacks 118 
The role of prospective consent within a research participation register framework is to allow individual 119 
members of the public to have the choice of being actively involved in the process of research consent and 120 
participation.  Each participant can be given the opportunity to decide on the number and types of research 121 
studies in which they want to be involved depending on their current state of health.  Such freedom of choice 122 
around participation has the potential to allow prospective participants to play a more informed role in 123 
research16.  Being offered to take part in suitable potential studies and having the freedom to choose is likely 124 
to increase individuals’ willingness to participate in research they feel to be worthwhile. For example, 125 
Pullman17 found that people join registers, such as bio-banks, to take up an opportunity to be altruistic. 126 
Research investigating the motivation of those people who enrolled into SHARE found that contributing to 127 
research for the ‘common good’ and a sense of altruism was important to patients18.  With suitable safeguards 128 
and clear information, joining a research register may promote autonomy in decision-making about 129 
participation in research19,20.  130 
The implementation of a research register could encourage commercial and non-commercial research at a 131 
time when commercial collaborations are being particularly encouraged21.  The Scottish Diabetes Research 132 
Network saw an increase of 21% in the number of commercial companies and a 28% increase in academic 133 
studies using their register between 2010 and 2011, and both academic and non-academic organisations are 134 
keen to use prospective consent research registers22.  Some people do not wish to participate in some 135 
commercial studies18 but this can be easily arranged within the register. 136 
There are several key issues involved in the establishment and continued development of research registers.  137 
These include the need for a broad base of volunteer participants joining research registers and ensuring that 138 
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minority groups are included to reflect the diversity of the population. Secure storage of data and robust 139 
governance policies are important to ensure participants have confidence in their security and confidentiality 140 
and to ensure research is being conducted to the highest ethical standards.  A well-structured policy on 141 
commercial companies seeking access to participatory research registers is essential to ensure registrants have 142 
clear choices about what type of research they engage with. A flexible participant interface has been identified 143 
as key to effective communication between potential research participants and researchers, as well as 144 
providing an online participant facility to control prospective consent23. For example, the ‘dynamic consent’ 145 
model is a new approach to online prospective consent and management that seeks to increase engagement 146 
from participants regarding the use of their personal data23.  It is in effect an online secure log-in account for 147 
each individual involved in a register to allow them to manage and control their own research profile and 148 
update consent preferences in real time.   Such a flexible interface also mitigates the need for regular and 149 
often cumbersome re-consent procedures.  150 
The durability of consent has been highlighted as a potential issue because there could be considerable time 151 
lapses between participants providing consent and being re-contacted for future research24.  Research 152 
conducted during the establishment of the SHARE register found that patients were ambivalent about making 153 
open-ended commitments when they agreed to join the register18, which implies that regular re-consent was 154 
not a high priority issue.  Some registers advocate re-consenting; for example, ‘ResearchMatch’ contacts all 155 
participants who have not logged in their online account in 12 months to ensure continued interest, and the 156 
Illinois Women's Health Registry requests re-consent yearly5,6.  Although many registers do not ask for re-157 
consent within repeated time frames directly, many are in regular contact with participants online or through 158 
newsletters, which provides the opportunity for participants to be reminded of their role in the register and of 159 
options to withdraw if they wish. 160 
There are important ethical issues associated with all types of consent, such as an individual’s mental capacity 161 
to consent, the information provided to individuals and the voluntary nature of the consent. The aim of 162 
prospective consent is to create an environment in which participants can be informed about new studies for 163 
which they are eligible, while ensuring that potential participants give consent in the usual way to be entered 164 
into specific trials or projects.   165 
  166 
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Summary 167 
 Seeking prospective consent from patients and members of the public, using a register format, could increase 168 
participation in health research without compromising informed consent and other ethical principles. 169 
Prospective consent is a proactive approach to improving access to health research and could become part of 170 
everyday clinical care within hospital and general practice2.  If fully integrated into the research process, 171 
research registers with prospective consent for re-contact could increase participation enhance the reliability 172 
and validity of future research.  Research registers support the public and patients to move away from 173 
passively waiting for an approach about a relevant study towards being able to actively express an interest in 174 
participation in health research. They help match interested people to good quality research projects that are 175 
likely to suit them. This will speed up research studies and bringing new treatments into routine use.   The 176 
creation of a more dynamic link between participants and researchers could create a community approach to 177 
the improvement of health services through research. 178 
 179 
 180 
 181 
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